Entrectinib in patients with ROS1 fusion-positive (ROS1-fp) NSCLC: Updated efficacy and safety analysis Meeting Abstract
| Authors: | Fan, Y.; Drilon, A.; Chiu, C. H.; Bowles, D. W.; Loong, H. H. F.; Siena, S.; Goto, K.; Krzakowski, M.; Ahn, M. J.; Murakami, H.; Dziadziuszko, R.; Zeuner, H.; Pitcher, B.; Cheick, D.; Krebs, M. G. |
| Abstract Title: | Entrectinib in patients with ROS1 fusion-positive (ROS1-fp) NSCLC: Updated efficacy and safety analysis |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S89 |
| End Page: | S90 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.150 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: MA13.04 -- Located within section named "MA13 Update on ROS1 Inhibitors and New Pathways" -- Accession Number: 159037396 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
